🟢 Connect Biopharma is trading 6.43% up in pre-market; no specific catalyst identified

Connect Biopharma is trading 6.43% up at $0.83 in pre-market on November 3; available information does not establish a specific catalyst.

• No new company-specific announcement explaining the move surfaced.
• Nasdaq lists November 11 as the estimated earnings date; this is not an earnings release for November 3.
• The broader market backdrop is mixed, with major index futures mostly lower, and does not clearly explain the gain. Trading volume and activity details were not provided.